Type 1 diabetes trials in Saudi Arabia
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEarly Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
- Where
- Dammam, Jeddah, Riyadh
- Age
- 18 months to 18 years
- People
- 3,500 worldwide
- Run by
- Sanofi
See details and how to joinNCT07038473 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Riyadh
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - Phase 2Not yet taking people in Saudi ArabiaSHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- Where
- Riyadh
- Age
- 18 years to 50 years
- People
- 240
- Run by
- Ministry of Health, Saudi Arabia
See details and how to joinNCT07614412 - Phase 3Taking peopleAn Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Where
- Riyadh
- Age
- 18 years to 65 years
- People
- 10 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT06832410 - Phase 4Not yet taking people in Saudi ArabiaCan the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
- Where
- Riyadh
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Dasman Diabetes Institute
See details and how to joinNCT06922656 - No phaseTaking peopleScreening Program for Type 1 Diabetes in a High-Risk Population
- Where
- Riyadh
- Age
- 2 years to 18 years
- People
- 1,300
- Run by
- King Saud University
See details and how to joinNCT06513247